Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 22 10 2021
revised: 11 01 2022
accepted: 17 01 2022
pubmed: 15 3 2022
medline: 13 4 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Gender-specific differences in thrombosis have been reported in hospitalized patients with COVID-19. We sought to investigate the influence of age on the relation between gender and incident thrombosis or death in COVID-19. We identified consecutive adults aged ≥18 years hospitalized with COVID-19 from March 1, 2020, to April 17, 2020, at a large New York health system. In-hospital thrombosis and all-cause mortality were evaluated by gender and stratified by age group. Logistic regression models were generated to estimate the odds of thrombosis or death after multivariable adjustment. In 3,334 patients hospitalized with COVID-19, 61% were men. Death or thrombosis occurred in 34% of hospitalizations and was more common in men (36% vs 29% in women, p <0.001; adjusted odds ratio [aOR] 1.61, 95% confidence interval [CI] 1.36 to 1.91). When stratified by age, men had a higher incidence of death or thrombosis in younger patients (aged 18 to 54 years: 21% vs 9%, aOR 3.17, 95% CI 2.06 to 5.01; aged 55 to 74 years: 39% vs 28%, aOR 1.63, 95% CI 1.28 to 2.10), but not older patients (aged ≥75 years: 55% vs 48%; aOR 1.20, 95% CI 0.90 to 1.59) (interaction p value: 0.01). For the individual end points, men were at higher risk of thrombosis (19% vs 12%; aOR 1.65, 95% CI 1.33 to 2.05) and mortality (26% vs 23%; aOR 1.41, 95% CI 1.17 to 1.69) than women, and gender-specific differences were attenuated with older age. Associations between thrombosis and mortality were most striking in younger patients (aged 18 to 54 years, aOR 8.25; aged 55 to 74 years, aOR 2.38; aged >75 years, aOR 1.88; p for interaction <0.001) but did not differ by gender. In conclusion, the risk of thrombosis or death in COVID-19 is higher in men compared with women and is most apparent in younger age groups.

Identifiants

pubmed: 35282877
pii: S0002-9149(22)00086-8
doi: 10.1016/j.amjcard.2022.01.024
pmc: PMC8908016
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-117

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL150315
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139909
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL144993
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
Sci Rep. 2021 Feb 18;11(1):4053
pubmed: 33602977
J Atheroscler Thromb. 2018 Nov 1;25(11):1091-1104
pubmed: 29540637
Intern Emerg Med. 2020 Apr;15(3):453-462
pubmed: 31691119
Blood Transfus. 2011 Apr;9(2):120-38
pubmed: 21084000
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Immunology. 2000 Jul;100(3):384-90
pubmed: 10929062
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
JAMA Netw Open. 2020 Apr 1;3(4):e205619
pubmed: 32275319
Mayo Clin Proc. 2020 Oct;95(10):2189-2203
pubmed: 33012349
Am Heart J. 2021 Jan;231:93-95
pubmed: 33181067
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Intern Med. 2012 Jun;271(6):608-18
pubmed: 22026462
J Immunol. 2017 May 15;198(10):4046-4053
pubmed: 28373583
N Engl J Med. 1999 Jul 22;341(4):217-25
pubmed: 10413733
JAMA. 2020 Aug 25;324(8):799-801
pubmed: 32702090
Hypertension. 2012 Oct;60(4):878-83
pubmed: 22926952
Int J Med Inform. 2017 May;101:93-99
pubmed: 28347453
JAMA Intern Med. 2013 May 13;173(9):743-52
pubmed: 23546607
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
JACC Case Rep. 2020 Jul 15;2(9):1407-1410
pubmed: 32373791
Front Immunol. 2019 Nov 05;10:2569
pubmed: 31749809
Mayo Clin Proc. 2020 Aug;95(8):1613-1620
pubmed: 32753136
Immunity. 2020 Sep 15;53(3):487-495
pubmed: 32853545
Blood Rev. 2014 May;28(3):123-33
pubmed: 24768093
J Thromb Haemost. 2014 Oct;12(10):1593-600
pubmed: 25081183
J Clin Invest. 2017 Jan 3;127(1):169-182
pubmed: 27893465

Auteurs

Tanya Wilcox (T)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.

Nathaniel R Smilowitz (NR)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.

Bilaloglu Seda (B)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.

Yuhe Xia (Y)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.

Judith Hochman (J)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.

Jeffrey S Berger (JS)

The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York. Electronic address: jeffrey.berger@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH